MNTN MNTN
- Market cap
- $724.1M
- PE
- 12.9×
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 2.3×
- EV/EBIT
- 10.5×
- Revenue, 12 months
- $313.3M
- +21% on a year ago
- Net margin
- 18.0%
- Free cash flow yield
- n/m
- not a meaningful number
MNTN trades at 12.9× trailing earnings. Revenue was $313.3M over the last twelve months, up 21% on a year earlier with a 18% net margin.
Charts
Financials
| Income statement | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| $43.8M | $54.8M | $57.1M | $69.8M | $64.5M+47% | $68.5M+25% | $70M+23% | $87.1M+25% | $73.7M+14% | $82.5M+21% | |
| Cost of revenue | $15M | $16.7M | $16.2M | $16.2M | $19.8M+32% | $15.9M−5% | $14.8M−9% | $15.6M−3% | $13.7M−31% | $16.2M+2% |
| Gross profit | $28.8M | $38.1M | $40.9M | $53.6M | $44.7M+55% | $52.6M+38% | $55.2M+35% | $71.5M+33% | $60M+34% | $66.3M+26% |
| R&D | $7.8M | $7.8M | $8.2M | $8.9M | $9.6M+23% | $10.7M+38% | $13.7M+68% | $15.2M+71% | $14.6M+52% | $16.4M+52% |
| SG&A | $29.9M | $32M | $31.8M | $34.2M | $42.1M+41% | $37.5M+17% | $33.3M+5% | $35.1M+3% | $35.2M−17% | $42.2M+13% |
| −$9.6M | −$2.3M | $374K | $9.9M | −$7.7M−20% | $3.7M | $7.5M+1913% | $20.5M+108% | $9.6M | $7.1M+92% | |
| Pre-tax income | −$15.7M | −$9.2M | −$3.8M | $1.6M | −$25.4M+62% | −$24.2M+165% | $8.4M | $25.3M+1505% | $11.6M | $9.2M |
| $11K | $122K | $58K | $5.6M | −$4.3M | $2M+1528% | $1.9M+3255% | −$9.2M | $2.9M | $2.4M+23% | |
| Net income | −$15.7M | −$9.3M | −$3.9M | −$4M | −$21.1M+35% | −$26.2M+183% | $6.4M | $34.5M | $8.8M | $6.7M |
| −$1.17 | −$0.69 | −$0.28 | −$0.28 | −$1.41+21% | −$0.65−6% | $0.08 | $0.47 | $0.11 | $0.09 | |
| 13.4M | 13.5M | 14.1M | 14.2M | 15M+12% | 40.1M+198% | 80.7M+473% | 73.8M+418% | 78.9M+425% | 78.6M+96% |
Revenue: Q1 FY24 and Q1 FY25: 6 months less the 3 months printed beside them.
Cost of revenue: Q1 FY24 and Q1 FY25: 6 months less the 3 months printed beside them.
Gross profit: Q1 FY24 and Q1 FY25: 6 months less the 3 months printed beside them.
R&D: Q1 FY24 and Q1 FY25: 6 months less the 3 months printed beside them.
SG&A: Q1 FY24 and Q1 FY25: 6 months less the 3 months printed beside them.
Operating income: Q1 FY24 and Q1 FY25: 6 months less the 3 months printed beside them.
Pre-tax income: Q1 FY24 and Q1 FY25: 6 months less the 3 months printed beside them.
Income tax: Q1 FY24 and Q1 FY25: 6 months less the 3 months printed beside them.
Net income: Q1 FY24 and Q1 FY25: 6 months less the 3 months printed beside them.
EPS, diluted: 3 periods, Q1 FY24 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: Q1 FY24: share-days: the 6-month average less the second quarter's. Q4 FY24: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Software - Application nearest MNTN's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| MNTNMNTN | $724.1M | 12.9× | 15.1× | 2.3× | +21% | 18.0% | |
| YEXTYext | $727.5M | 38.7× | 48.3× | 1.6× | −1% | 5.9% | |
| NRDSNerdwallet | $698.7M | 12.3× | 15.9× | 0.8× | +12% | 7.6% | |
| TASKTaskUs | $784.8M | 7.4× | 26.3× | 0.6× | +11% | 8.8% | |
| EVEREverQuote | $801.4M | 7.4× | 18.5× | 1.1× | +23% | 15.2% | |
| IBEXIBEX | $627.1M | 15.1× | 11.5× | 1.0× | +15% | 7.2% | |
| CARSCars.com | $585.6M | 19.2× | 27.3× | 0.8× | +1% | 4.7% | |
| OOMAOoma | $545.7M | 52.0× | 124× | 1.8× | +17% | 3.6% | |
| HSTMHealthstream | $1B | 48.8× | 54.3× | 3.2× | +9% | 6.6% | |
| UPWKUpwork | $1.2B | 12.5× | 15.9× | 1.5× | +2% | 12.9% | |
| LZLegalzoom.Com | $1.2B | 77.7× | 68.5× | 1.5× | +12% | 2.1% | |
| Peer median | $756.2M | 17.1× | 26.8× | 1.3× | +11% | 6.9% |
Investors who own it
Investors we follow who held MNTN at the end of Jun 30, 2026, from their 13F filings.
- Chase ColemanTiger Global Management0.0% of portfolio
More on MNTN
Each number over time
Where it ranks
Its groups
About
- Industry
- Software - Application
- Sector
- Technology
Valuation data, not investment advice. Prices as of .